Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1990
Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice
M H Shearer, R L Lanford, R C Kennedy
Molecular Immunology
|
April 13, 1999
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen
M H Shearer, C Sureau, B Dunbar, et al.
Cancer Research
|
March 1, 1996
Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen
R K Bright, B Beames, M H Shearer, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 5, 1999
Comparison and characterization of immunoglobulin G subclasses among primate species
M H Shearer, R D Dark, J Chodosh, et al.
Developments in Biological Standardization
|
October 17, 1998
Immunotherapy of SV40 induced tumours in mice: a model for vaccine development
R K Bright, M H Shearer, H I Pass, et al.
Cellular and Molecular Life Sciences : CMLS
|
January 30, 2007
SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen
D B Lowe, M H Shearer, C A Jumper, et al.
Journal of Virological Methods
|
March 21, 1998
Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen
A M Watts, M H Shearer, H I Pass, et al.
AIDS Research and Human Retroviruses
|
January 11, 2000
Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity
M H Shearer, A G Dalgleish, T C Chanh, et al.
Clinical and Experimental Immunology
|
February 1, 1993
Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells
M H Shearer, R K Bright, R E Lanford, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 15, 2007
Towards progress on DNA vaccines for cancer
D B Lowe, M H Shearer, C A Jumper, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1990
Monoclonal anti-idiotypic antibodies induce humoral immune responses specific for simian virus 40 large tumor antigen in mice
M H Shearer, R L Lanford, R C Kennedy
Molecular Immunology
|
April 13, 1999
Structural characterization of viral neutralizing monoclonal antibodies to hepatitis B surface antigen
M H Shearer, C Sureau, B Dunbar, et al.
Cancer Research
|
March 1, 1996
Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen
R K Bright, B Beames, M H Shearer, et al.
Clinical and Diagnostic Laboratory Immunology
|
November 5, 1999
Comparison and characterization of immunoglobulin G subclasses among primate species
M H Shearer, R D Dark, J Chodosh, et al.
Developments in Biological Standardization
|
October 17, 1998
Immunotherapy of SV40 induced tumours in mice: a model for vaccine development
R K Bright, M H Shearer, H I Pass, et al.
Cellular and Molecular Life Sciences : CMLS
|
January 30, 2007
SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen
D B Lowe, M H Shearer, C A Jumper, et al.
Journal of Virological Methods
|
March 21, 1998
Development of an experimental murine pulmonary metastasis model incorporating a viral encoded tumor specific antigen
A M Watts, M H Shearer, H I Pass, et al.
AIDS Research and Human Retroviruses
|
January 11, 2000
Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activity
M H Shearer, A G Dalgleish, T C Chanh, et al.
Clinical and Experimental Immunology
|
February 1, 1993
Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells
M H Shearer, R K Bright, R E Lanford, et al.
Cellular and Molecular Life Sciences : CMLS
|
June 15, 2007
Towards progress on DNA vaccines for cancer
D B Lowe, M H Shearer, C A Jumper, et al.
Page
of 4